Notice Regarding Determination of Matters Related to Treasury Share Acquisition5/14 14:00TDnetPDF(100KB)
[Summary]Notice Regarding Disposition of Treasury Stock for Performance-Linked5/14 14:00TDnetPDF(96KB)
Consolidated Financial Statements for the Fiscal Year Ended March 31, 2026 [Japanese GAAP]5/14 14:00TDnetPDF(866KB)
Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2026 [Japanese GAAP]2/10 14:00TDnetPDF(375KB)
Notice Regarding Consolidated Subsidiary (MEDLEAP PHARMA COMPANY LIMITED) Notice Regarding the Initiation of Phase 2 Clinical Trial in Japan for Ferri2025/11/14TDnetPDF(402KB)
Notice Regarding Recording of Non-Operating Income and Notice Regarding Recording of Gain on Sales of Investment Securities (Extraordinary Income) Par2025/11/14TDnetPDF(152KB)
Notice Regarding Revision of Consolidated Financial Forecasts for Fiscal Year 20252025/11/14TDnetPDF(104KB)
Consolidated Financial Statements for the Second Quarter of the Fiscal Year Ending March 31, 2026 [Japanese GAAP]2025/11/14TDnetPDF(409KB)